Aquestive Therapeutics In...
3.04
-0.07 (-2.25%)
At close: Jan 14, 2025, 3:59 PM
3.06
0.49%
After-hours Jan 14, 2025, 04:07 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 50.58M 47.68M 50.83M 45.85M 52.61M 67.43M 66.92M 51.78M
Cost of Revenue 20.83M 19.39M 14.99M 12.96M 20.36M 20.99M 19.82M 16.38M
Gross Profit 29.75M 28.29M 35.84M 32.88M 32.25M 46.44M 47.10M 35.41M
Operating Income -15.10M -42.07M -34.68M -42.89M -52.67M -48.93M -113.00K -847.00K
Interest Income 16.32M 99.00K 423.00K 132.00K 636.00K 552.00K n/a n/a
Pretax Income -7.63M -54.41M -70.54M -55.78M -66.25M -61.38M -8.94M -9.60M
Net Income -7.87M -60.20M -90.04M -65.36M -72.66M -61.38M -8.94M -9.60M
Selling & General & Admin 31.75M 52.88M 53.48M 55.89M 64.34M 72.26M 25.08M 20.80M
Research & Development 13.10M 17.48M 17.05M 19.89M 20.57M 23.11M 22.13M 15.45M
Other Expenses n/a n/a n/a n/a n/a -5.00K n/a -99.00K
Operating Expenses 44.85M 70.36M 70.52M 75.78M 84.92M 95.38M 47.21M 36.25M
Interest Expense 7.46M 12.44M 22.46M 13.02M 9.32M 7.71M 7.71M 6.14M
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 65.69M 89.75M 85.51M 88.74M 105.28M 116.36M 67.03M 52.63M
Income Tax 245.00K 5.79M 19.50M 9.58M 6.41M -4.73M 7.71M 6.04M
Shares Outstanding (Basic) 61.26M 48.73M 38.08M 33.65M 25.36M 20.73M 20.00M 24.50M
Shares Outstanding (Diluted) 61.26M 48.73M 38.08M 33.65M 25.36M 20.73M 20.00M 24.50M
EPS (Basic) -0.13 -1.24 -2.36 -1.94 -2.87 -2.96 -0.45 -0.39
EPS (Diluted) -0.13 -1.24 -2.36 -1.94 -2.87 -2.96 -0.45 -0.39
EBITDA 1.18M -39.58M -45.11M -39.15M -53.88M -50.33M 2.56M 2.94M
Depreciation & Amortization 1.34M 2.39M 2.96M 3.61M 3.05M 3.34M 3.80M 3.89M

Create Price Alert on AQST

Your price alert will notify you when the stock price is above 3.04.

Add to Watchlist